Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-01-07 @ 9:54 PM
Study NCT ID:
NCT03258593
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2017-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-22
First Submit QC Date:
None
Study First Post Date:
2017-08-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-29
Results First Submit QC Date:
None
Results First Post Date:
2023-10-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-08-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED